
    
      This is a randomized, parallel trial with blinded outcome assessment. The sample will include
      adult patients (aged â‰¥18 years) with a diagnosis of HF-PEF admitted for HF decompensation.
      The patients will be randomized to receive a diet with sodium and fluid intake restricted to
      0.8 g/day and 800 mL/day respectively (intervention group) or an unrestricted diet, with 4
      g/day sodium and unlimited fluid intake (control group), and followed for 7 days or until
      hospital discharge. The primary outcome shall consist of weight loss at 7 days or discharge.
      The secondary outcome includes assessment of clinical stability, neurohormonal activation,
      daily perception of thirst and readmission rate at 30 days.
    
  